Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

Trial Details

NCT ID

NCT03659448

Phase

PHASE3

Sponsor

Surgimab

Status

RECRUITING

Cancer Type

Colon Cancer Colorectal Cancer

Interventions

• SGM-101

Locations (sample)

• Duarte, California, United States|34.13945,-117.97729
• La Jolla, California, United States|32.84727,-117.2742
• Weston, Florida, United States|26.10037,-80.39977
• Boston, Massachusetts, United States|42.35843,-71.05977
• Worcester, Massachusetts, United States|42.26259,-71.80229

Key Eligibility Criteria

• Patients should be scheduled for curative colorectal cancer surgery of primary cT4 colon cancer or primary cT3/4 rectal cancer, recurrent colorecta…
• Female patients must be of non-child-bearing potential (i.e., women with functioning ovaries who have a documented tubal ligation or hysterectomy, …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.